Active Pharma Ingredient Market - Global Outlook and Forecast 2022-2028
This report contains market size and forecasts of Active Pharma Ingredient in global, including the following market information:
Global Active Pharma Ingredient Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Active Pharma Ingredient Market Sales, 2017-2022, 2023-2028, (K Pcs)
Global top five Active Pharma Ingredient companies in 2021 (%)
The global Active Pharma Ingredient market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Innovative Active Pharmaceutical Ingredients Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Active Pharma Ingredient include Teva, Novartis, Pfizer, Johnson & Johnson, Mylan, North China Pharmaceutical Group, Dr. Reddy’s Laboratories, Roche and Aurobindo pharma, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Active Pharma Ingredient manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Active Pharma Ingredient Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Pcs)
Global Active Pharma Ingredient Market Segment Percentages, by Type, 2021 (%)
Global Active Pharma Ingredient Market Segment Percentages, by Application, 2021 (%)
Global Active Pharma Ingredient Market Segment Percentages, By Region and Country, 2021 (%)
The report also provides analysis of leading market participants including:
Key companies Active Pharma Ingredient revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Active Pharma Ingredient revenues share in global market, 2021 (%)
Key companies Active Pharma Ingredient sales in global market, 2017-2022 (Estimated), (K Pcs)
Key companies Active Pharma Ingredient sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Global Active Pharma Ingredient Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Active Pharma Ingredient Market Sales, 2017-2022, 2023-2028, (K Pcs)
Global top five Active Pharma Ingredient companies in 2021 (%)
The global Active Pharma Ingredient market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Innovative Active Pharmaceutical Ingredients Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Active Pharma Ingredient include Teva, Novartis, Pfizer, Johnson & Johnson, Mylan, North China Pharmaceutical Group, Dr. Reddy’s Laboratories, Roche and Aurobindo pharma, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Active Pharma Ingredient manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Active Pharma Ingredient Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Pcs)
Global Active Pharma Ingredient Market Segment Percentages, by Type, 2021 (%)
- Innovative Active Pharmaceutical Ingredients
- Generic Active Pharmaceutical Ingredients
Global Active Pharma Ingredient Market Segment Percentages, by Application, 2021 (%)
- Oncology
- Cardiovascular Disease
- Diabetes
- Central Nervous System and Neurological Disorders
- Endocrinology
- Other Therapeutic Applications
Global Active Pharma Ingredient Market Segment Percentages, By Region and Country, 2021 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
The report also provides analysis of leading market participants including:
Key companies Active Pharma Ingredient revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Active Pharma Ingredient revenues share in global market, 2021 (%)
Key companies Active Pharma Ingredient sales in global market, 2017-2022 (Estimated), (K Pcs)
Key companies Active Pharma Ingredient sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
- Teva
- Novartis
- Pfizer
- Johnson & Johnson
- Mylan
- North China Pharmaceutical Group
- Dr. Reddy’s Laboratories
- Roche
- Aurobindo pharma
- Sun Pharmaceutical Industries
- Boehringer Ingelheim GmbH
- Bayer
- BASF
- DSM
- Zhejiang Medicine
- Biocon
- Johnson Matthey
- Hisun Pharmacy
- Cambrex
- Shandong Xinhua Pharmaceutical
- Lonza group
- Huahai Pharmaceutical
- Haerbin Pharmaceutical Group
- Cipla
- Tian Yao
- Lupin
- North East Pharmaceutical
- Albemarle
- Shandong Lukang Pharmaceutical
- Jiangsu Hengrui Medicine
1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS
1.1 Active Pharma Ingredient Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Active Pharma Ingredient Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 GLOBAL ACTIVE PHARMA INGREDIENT OVERALL MARKET SIZE
2.1 Global Active Pharma Ingredient Market Size: 2021 VS 2028
2.2 Global Active Pharma Ingredient Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Active Pharma Ingredient Sales: 2017-2028
3 COMPANY LANDSCAPE
3.1 Top Active Pharma Ingredient Players in Global Market
3.2 Top Global Active Pharma Ingredient Companies Ranked by Revenue
3.3 Global Active Pharma Ingredient Revenue by Companies
3.4 Global Active Pharma Ingredient Sales by Companies
3.5 Global Active Pharma Ingredient Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Active Pharma Ingredient Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Active Pharma Ingredient Product Type
3.8 Tier 1, Tier 2 and Tier 3 Active Pharma Ingredient Players in Global Market
3.8.1 List of Global Tier 1 Active Pharma Ingredient Companies
3.8.2 List of Global Tier 2 and Tier 3 Active Pharma Ingredient Companies
4 SIGHTS BY PRODUCT
4.1 Overview
4.1.1 By Type - Global Active Pharma Ingredient Market Size Markets, 2021 & 2028
4.1.2 Innovative Active Pharmaceutical Ingredients
4.1.3 Generic Active Pharmaceutical Ingredients
4.2 By Type - Global Active Pharma Ingredient Revenue & Forecasts
4.2.1 By Type - Global Active Pharma Ingredient Revenue, 2017-2022
4.2.2 By Type - Global Active Pharma Ingredient Revenue, 2023-2028
4.2.3 By Type - Global Active Pharma Ingredient Revenue Market Share, 2017-2028
4.3 By Type - Global Active Pharma Ingredient Sales & Forecasts
4.3.1 By Type - Global Active Pharma Ingredient Sales, 2017-2022
4.3.2 By Type - Global Active Pharma Ingredient Sales, 2023-2028
4.3.3 By Type - Global Active Pharma Ingredient Sales Market Share, 2017-2028
4.4 By Type - Global Active Pharma Ingredient Price (Manufacturers Selling Prices), 2017-2028
5 SIGHTS BY APPLICATION
5.1 Overview
5.1.1 By Application - Global Active Pharma Ingredient Market Size, 2021 & 2028
5.1.2 Oncology
5.1.3 Cardiovascular Disease
5.1.4 Diabetes
5.1.5 Central Nervous System and Neurological Disorders
5.1.6 Endocrinology
5.1.7 Other Therapeutic Applications
5.2 By Application - Global Active Pharma Ingredient Revenue & Forecasts
5.2.1 By Application - Global Active Pharma Ingredient Revenue, 2017-2022
5.2.2 By Application - Global Active Pharma Ingredient Revenue, 2023-2028
5.2.3 By Application - Global Active Pharma Ingredient Revenue Market Share, 2017-2028
5.3 By Application - Global Active Pharma Ingredient Sales & Forecasts
5.3.1 By Application - Global Active Pharma Ingredient Sales, 2017-2022
5.3.2 By Application - Global Active Pharma Ingredient Sales, 2023-2028
5.3.3 By Application - Global Active Pharma Ingredient Sales Market Share, 2017-2028
5.4 By Application - Global Active Pharma Ingredient Price (Manufacturers Selling Prices), 2017-2028
6 SIGHTS BY REGION
6.1 By Region - Global Active Pharma Ingredient Market Size, 2021 & 2028
6.2 By Region - Global Active Pharma Ingredient Revenue & Forecasts
6.2.1 By Region - Global Active Pharma Ingredient Revenue, 2017-2022
6.2.2 By Region - Global Active Pharma Ingredient Revenue, 2023-2028
6.2.3 By Region - Global Active Pharma Ingredient Revenue Market Share, 2017-2028
6.3 By Region - Global Active Pharma Ingredient Sales & Forecasts
6.3.1 By Region - Global Active Pharma Ingredient Sales, 2017-2022
6.3.2 By Region - Global Active Pharma Ingredient Sales, 2023-2028
6.3.3 By Region - Global Active Pharma Ingredient Sales Market Share, 2017-2028
6.4 North America
6.4.1 By Country - North America Active Pharma Ingredient Revenue, 2017-2028
6.4.2 By Country - North America Active Pharma Ingredient Sales, 2017-2028
6.4.3 US Active Pharma Ingredient Market Size, 2017-2028
6.4.4 Canada Active Pharma Ingredient Market Size, 2017-2028
6.4.5 Mexico Active Pharma Ingredient Market Size, 2017-2028
6.5 Europe
6.5.1 By Country - Europe Active Pharma Ingredient Revenue, 2017-2028
6.5.2 By Country - Europe Active Pharma Ingredient Sales, 2017-2028
6.5.3 Germany Active Pharma Ingredient Market Size, 2017-2028
6.5.4 France Active Pharma Ingredient Market Size, 2017-2028
6.5.5 U.K. Active Pharma Ingredient Market Size, 2017-2028
6.5.6 Italy Active Pharma Ingredient Market Size, 2017-2028
6.5.7 Russia Active Pharma Ingredient Market Size, 2017-2028
6.5.8 Nordic Countries Active Pharma Ingredient Market Size, 2017-2028
6.5.9 Benelux Active Pharma Ingredient Market Size, 2017-2028
6.6 Asia
6.6.1 By Region - Asia Active Pharma Ingredient Revenue, 2017-2028
6.6.2 By Region - Asia Active Pharma Ingredient Sales, 2017-2028
6.6.3 China Active Pharma Ingredient Market Size, 2017-2028
6.6.4 Japan Active Pharma Ingredient Market Size, 2017-2028
6.6.5 South Korea Active Pharma Ingredient Market Size, 2017-2028
6.6.6 Southeast Asia Active Pharma Ingredient Market Size, 2017-2028
6.6.7 India Active Pharma Ingredient Market Size, 2017-2028
6.7 South America
6.7.1 By Country - South America Active Pharma Ingredient Revenue, 2017-2028
6.7.2 By Country - South America Active Pharma Ingredient Sales, 2017-2028
6.7.3 Brazil Active Pharma Ingredient Market Size, 2017-2028
6.7.4 Argentina Active Pharma Ingredient Market Size, 2017-2028
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Active Pharma Ingredient Revenue, 2017-2028
6.8.2 By Country - Middle East & Africa Active Pharma Ingredient Sales, 2017-2028
6.8.3 Turkey Active Pharma Ingredient Market Size, 2017-2028
6.8.4 Israel Active Pharma Ingredient Market Size, 2017-2028
6.8.5 Saudi Arabia Active Pharma Ingredient Market Size, 2017-2028
6.8.6 UAE Active Pharma Ingredient Market Size, 2017-2028
7 MANUFACTURERS & BRANDS PROFILES
7.1 Teva
7.1.1 Teva Corporate Summary
7.1.2 Teva Business Overview
7.1.3 Teva Active Pharma Ingredient Major Product Offerings
7.1.4 Teva Active Pharma Ingredient Sales and Revenue in Global (2017-2022)
7.1.5 Teva Key News
7.2 Novartis
7.2.1 Novartis Corporate Summary
7.2.2 Novartis Business Overview
7.2.3 Novartis Active Pharma Ingredient Major Product Offerings
7.2.4 Novartis Active Pharma Ingredient Sales and Revenue in Global (2017-2022)
7.2.5 Novartis Key News
7.3 Pfizer
7.3.1 Pfizer Corporate Summary
7.3.2 Pfizer Business Overview
7.3.3 Pfizer Active Pharma Ingredient Major Product Offerings
7.3.4 Pfizer Active Pharma Ingredient Sales and Revenue in Global (2017-2022)
7.3.5 Pfizer Key News
7.4 Johnson & Johnson
7.4.1 Johnson & Johnson Corporate Summary
7.4.2 Johnson & Johnson Business Overview
7.4.3 Johnson & Johnson Active Pharma Ingredient Major Product Offerings
7.4.4 Johnson & Johnson Active Pharma Ingredient Sales and Revenue in Global (2017-2022)
7.4.5 Johnson & Johnson Key News
7.5 Mylan
7.5.1 Mylan Corporate Summary
7.5.2 Mylan Business Overview
7.5.3 Mylan Active Pharma Ingredient Major Product Offerings
7.5.4 Mylan Active Pharma Ingredient Sales and Revenue in Global (2017-2022)
7.5.5 Mylan Key News
7.6 North China Pharmaceutical Group
7.6.1 North China Pharmaceutical Group Corporate Summary
7.6.2 North China Pharmaceutical Group Business Overview
7.6.3 North China Pharmaceutical Group Active Pharma Ingredient Major Product Offerings
7.6.4 North China Pharmaceutical Group Active Pharma Ingredient Sales and Revenue in Global (2017-2022)
7.6.5 North China Pharmaceutical Group Key News
7.7 Dr. Reddy’s Laboratories
7.7.1 Dr. Reddy’s Laboratories Corporate Summary
7.7.2 Dr. Reddy’s Laboratories Business Overview
7.7.3 Dr. Reddy’s Laboratories Active Pharma Ingredient Major Product Offerings
7.7.4 Dr. Reddy’s Laboratories Active Pharma Ingredient Sales and Revenue in Global (2017-2022)
7.7.5 Dr. Reddy’s Laboratories Key News
7.8 Roche
7.8.1 Roche Corporate Summary
7.8.2 Roche Business Overview
7.8.3 Roche Active Pharma Ingredient Major Product Offerings
7.8.4 Roche Active Pharma Ingredient Sales and Revenue in Global (2017-2022)
7.8.5 Roche Key News
7.9 Aurobindo pharma
7.9.1 Aurobindo pharma Corporate Summary
7.9.2 Aurobindo pharma Business Overview
7.9.3 Aurobindo pharma Active Pharma Ingredient Major Product Offerings
7.9.4 Aurobindo pharma Active Pharma Ingredient Sales and Revenue in Global (2017-2022)
7.9.5 Aurobindo pharma Key News
7.10 Sun Pharmaceutical Industries
7.10.1 Sun Pharmaceutical Industries Corporate Summary
7.10.2 Sun Pharmaceutical Industries Business Overview
7.10.3 Sun Pharmaceutical Industries Active Pharma Ingredient Major Product Offerings
7.10.4 Sun Pharmaceutical Industries Active Pharma Ingredient Sales and Revenue in Global (2017-2022)
7.10.5 Sun Pharmaceutical Industries Key News
7.11 Boehringer Ingelheim GmbH
7.11.1 Boehringer Ingelheim GmbH Corporate Summary
7.11.2 Boehringer Ingelheim GmbH Active Pharma Ingredient Business Overview
7.11.3 Boehringer Ingelheim GmbH Active Pharma Ingredient Major Product Offerings
7.11.4 Boehringer Ingelheim GmbH Active Pharma Ingredient Sales and Revenue in Global (2017-2022)
7.11.5 Boehringer Ingelheim GmbH Key News
7.12 Bayer
7.12.1 Bayer Corporate Summary
7.12.2 Bayer Active Pharma Ingredient Business Overview
7.12.3 Bayer Active Pharma Ingredient Major Product Offerings
7.12.4 Bayer Active Pharma Ingredient Sales and Revenue in Global (2017-2022)
7.12.5 Bayer Key News
7.13 BASF
7.13.1 BASF Corporate Summary
7.13.2 BASF Active Pharma Ingredient Business Overview
7.13.3 BASF Active Pharma Ingredient Major Product Offerings
7.13.4 BASF Active Pharma Ingredient Sales and Revenue in Global (2017-2022)
7.13.5 BASF Key News
7.14 DSM
7.14.1 DSM Corporate Summary
7.14.2 DSM Business Overview
7.14.3 DSM Active Pharma Ingredient Major Product Offerings
7.14.4 DSM Active Pharma Ingredient Sales and Revenue in Global (2017-2022)
7.14.5 DSM Key News
7.15 Zhejiang Medicine
7.15.1 Zhejiang Medicine Corporate Summary
7.15.2 Zhejiang Medicine Business Overview
7.15.3 Zhejiang Medicine Active Pharma Ingredient Major Product Offerings
7.15.4 Zhejiang Medicine Active Pharma Ingredient Sales and Revenue in Global (2017-2022)
7.15.5 Zhejiang Medicine Key News
7.16 Biocon
7.16.1 Biocon Corporate Summary
7.16.2 Biocon Business Overview
7.16.3 Biocon Active Pharma Ingredient Major Product Offerings
7.16.4 Biocon Active Pharma Ingredient Sales and Revenue in Global (2017-2022)
7.16.5 Biocon Key News
7.17 Johnson Matthey
7.17.1 Johnson Matthey Corporate Summary
7.17.2 Johnson Matthey Business Overview
7.17.3 Johnson Matthey Active Pharma Ingredient Major Product Offerings
7.17.4 Johnson Matthey Active Pharma Ingredient Sales and Revenue in Global (2017-2022)
7.17.5 Johnson Matthey Key News
7.18 Hisun Pharmacy
7.18.1 Hisun Pharmacy Corporate Summary
7.18.2 Hisun Pharmacy Business Overview
7.18.3 Hisun Pharmacy Active Pharma Ingredient Major Product Offerings
7.18.4 Hisun Pharmacy Active Pharma Ingredient Sales and Revenue in Global (2017-2022)
7.18.5 Hisun Pharmacy Key News
7.19 Cambrex
7.19.1 Cambrex Corporate Summary
7.19.2 Cambrex Business Overview
7.19.3 Cambrex Active Pharma Ingredient Major Product Offerings
7.19.4 Cambrex Active Pharma Ingredient Sales and Revenue in Global (2017-2022)
7.19.5 Cambrex Key News
7.20 Shandong Xinhua Pharmaceutical
7.20.1 Shandong Xinhua Pharmaceutical Corporate Summary
7.20.2 Shandong Xinhua Pharmaceutical Business Overview
7.20.3 Shandong Xinhua Pharmaceutical Active Pharma Ingredient Major Product Offerings
7.20.4 Shandong Xinhua Pharmaceutical Active Pharma Ingredient Sales and Revenue in Global (2017-2022)
7.20.5 Shandong Xinhua Pharmaceutical Key News
7.21 Lonza group
7.21.1 Lonza group Corporate Summary
7.21.2 Lonza group Business Overview
7.21.3 Lonza group Active Pharma Ingredient Major Product Offerings
7.21.4 Lonza group Active Pharma Ingredient Sales and Revenue in Global (2017-2022)
7.21.5 Lonza group Key News
7.22 Huahai Pharmaceutical
7.22.1 Huahai Pharmaceutical Corporate Summary
7.22.2 Huahai Pharmaceutical Business Overview
7.22.3 Huahai Pharmaceutical Active Pharma Ingredient Major Product Offerings
7.22.4 Huahai Pharmaceutical Active Pharma Ingredient Sales and Revenue in Global (2017-2022)
7.22.5 Huahai Pharmaceutical Key News
7.23 Haerbin Pharmaceutical Group
7.23.1 Haerbin Pharmaceutical Group Corporate Summary
7.23.2 Haerbin Pharmaceutical Group Business Overview
7.23.3 Haerbin Pharmaceutical Group Active Pharma Ingredient Major Product Offerings
7.23.4 Haerbin Pharmaceutical Group Active Pharma Ingredient Sales and Revenue in Global (2017-2022)
7.23.5 Haerbin Pharmaceutical Group Key News
7.24 Cipla
7.24.1 Cipla Corporate Summary
7.24.2 Cipla Business Overview
7.24.3 Cipla Active Pharma Ingredient Major Product Offerings
7.24.4 Cipla Active Pharma Ingredient Sales and Revenue in Global (2017-2022)
7.24.5 Cipla Key News
7.25 Tian Yao
7.25.1 Tian Yao Corporate Summary
7.25.2 Tian Yao Business Overview
7.25.3 Tian Yao Active Pharma Ingredient Major Product Offerings
7.25.4 Tian Yao Active Pharma Ingredient Sales and Revenue in Global (2017-2022)
7.25.5 Tian Yao Key News
7.26 Lupin
7.26.1 Lupin Corporate Summary
7.26.2 Lupin Business Overview
7.26.3 Lupin Active Pharma Ingredient Major Product Offerings
7.26.4 Lupin Active Pharma Ingredient Sales and Revenue in Global (2017-2022)
7.26.5 Lupin Key News
7.27 North East Pharmaceutical
7.27.1 North East Pharmaceutical Corporate Summary
7.27.2 North East Pharmaceutical Business Overview
7.27.3 North East Pharmaceutical Active Pharma Ingredient Major Product Offerings
7.27.4 North East Pharmaceutical Active Pharma Ingredient Sales and Revenue in Global (2017-2022)
7.27.5 North East Pharmaceutical Key News
7.28 Albemarle
7.28.1 Albemarle Corporate Summary
7.28.2 Albemarle Business Overview
7.28.3 Albemarle Active Pharma Ingredient Major Product Offerings
7.28.4 Albemarle Active Pharma Ingredient Sales and Revenue in Global (2017-2022)
7.28.5 Albemarle Key News
7.29 Shandong Lukang Pharmaceutical
7.29.1 Shandong Lukang Pharmaceutical Corporate Summary
7.29.2 Shandong Lukang Pharmaceutical Business Overview
7.29.3 Shandong Lukang Pharmaceutical Active Pharma Ingredient Major Product Offerings
7.29.4 Shandong Lukang Pharmaceutical Active Pharma Ingredient Sales and Revenue in Global (2017-2022)
7.29.5 Shandong Lukang Pharmaceutical Key News
7.30 Jiangsu Hengrui Medicine
7.30.1 Jiangsu Hengrui Medicine Corporate Summary
7.30.2 Jiangsu Hengrui Medicine Business Overview
7.30.3 Jiangsu Hengrui Medicine Active Pharma Ingredient Major Product Offerings
7.30.4 Jiangsu Hengrui Medicine Active Pharma Ingredient Sales and Revenue in Global (2017-2022)
7.30.5 Jiangsu Hengrui Medicine Key News
8 GLOBAL ACTIVE PHARMA INGREDIENT PRODUCTION CAPACITY, ANALYSIS
8.1 Global Active Pharma Ingredient Production Capacity, 2017-2028
8.2 Active Pharma Ingredient Production Capacity of Key Manufacturers in Global Market
8.3 Global Active Pharma Ingredient Production by Region
9 KEY MARKET TRENDS, OPPORTUNITY, DRIVERS AND RESTRAINTS
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 ACTIVE PHARMA INGREDIENT SUPPLY CHAIN ANALYSIS
10.1 Active Pharma Ingredient Industry Value Chain
10.2 Active Pharma Ingredient Upstream Market
10.3 Active Pharma Ingredient Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Active Pharma Ingredient Distributors and Sales Agents in Global
11 CONCLUSION
12 APPENDIX
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
1.1 Active Pharma Ingredient Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Active Pharma Ingredient Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 GLOBAL ACTIVE PHARMA INGREDIENT OVERALL MARKET SIZE
2.1 Global Active Pharma Ingredient Market Size: 2021 VS 2028
2.2 Global Active Pharma Ingredient Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Active Pharma Ingredient Sales: 2017-2028
3 COMPANY LANDSCAPE
3.1 Top Active Pharma Ingredient Players in Global Market
3.2 Top Global Active Pharma Ingredient Companies Ranked by Revenue
3.3 Global Active Pharma Ingredient Revenue by Companies
3.4 Global Active Pharma Ingredient Sales by Companies
3.5 Global Active Pharma Ingredient Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Active Pharma Ingredient Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Active Pharma Ingredient Product Type
3.8 Tier 1, Tier 2 and Tier 3 Active Pharma Ingredient Players in Global Market
3.8.1 List of Global Tier 1 Active Pharma Ingredient Companies
3.8.2 List of Global Tier 2 and Tier 3 Active Pharma Ingredient Companies
4 SIGHTS BY PRODUCT
4.1 Overview
4.1.1 By Type - Global Active Pharma Ingredient Market Size Markets, 2021 & 2028
4.1.2 Innovative Active Pharmaceutical Ingredients
4.1.3 Generic Active Pharmaceutical Ingredients
4.2 By Type - Global Active Pharma Ingredient Revenue & Forecasts
4.2.1 By Type - Global Active Pharma Ingredient Revenue, 2017-2022
4.2.2 By Type - Global Active Pharma Ingredient Revenue, 2023-2028
4.2.3 By Type - Global Active Pharma Ingredient Revenue Market Share, 2017-2028
4.3 By Type - Global Active Pharma Ingredient Sales & Forecasts
4.3.1 By Type - Global Active Pharma Ingredient Sales, 2017-2022
4.3.2 By Type - Global Active Pharma Ingredient Sales, 2023-2028
4.3.3 By Type - Global Active Pharma Ingredient Sales Market Share, 2017-2028
4.4 By Type - Global Active Pharma Ingredient Price (Manufacturers Selling Prices), 2017-2028
5 SIGHTS BY APPLICATION
5.1 Overview
5.1.1 By Application - Global Active Pharma Ingredient Market Size, 2021 & 2028
5.1.2 Oncology
5.1.3 Cardiovascular Disease
5.1.4 Diabetes
5.1.5 Central Nervous System and Neurological Disorders
5.1.6 Endocrinology
5.1.7 Other Therapeutic Applications
5.2 By Application - Global Active Pharma Ingredient Revenue & Forecasts
5.2.1 By Application - Global Active Pharma Ingredient Revenue, 2017-2022
5.2.2 By Application - Global Active Pharma Ingredient Revenue, 2023-2028
5.2.3 By Application - Global Active Pharma Ingredient Revenue Market Share, 2017-2028
5.3 By Application - Global Active Pharma Ingredient Sales & Forecasts
5.3.1 By Application - Global Active Pharma Ingredient Sales, 2017-2022
5.3.2 By Application - Global Active Pharma Ingredient Sales, 2023-2028
5.3.3 By Application - Global Active Pharma Ingredient Sales Market Share, 2017-2028
5.4 By Application - Global Active Pharma Ingredient Price (Manufacturers Selling Prices), 2017-2028
6 SIGHTS BY REGION
6.1 By Region - Global Active Pharma Ingredient Market Size, 2021 & 2028
6.2 By Region - Global Active Pharma Ingredient Revenue & Forecasts
6.2.1 By Region - Global Active Pharma Ingredient Revenue, 2017-2022
6.2.2 By Region - Global Active Pharma Ingredient Revenue, 2023-2028
6.2.3 By Region - Global Active Pharma Ingredient Revenue Market Share, 2017-2028
6.3 By Region - Global Active Pharma Ingredient Sales & Forecasts
6.3.1 By Region - Global Active Pharma Ingredient Sales, 2017-2022
6.3.2 By Region - Global Active Pharma Ingredient Sales, 2023-2028
6.3.3 By Region - Global Active Pharma Ingredient Sales Market Share, 2017-2028
6.4 North America
6.4.1 By Country - North America Active Pharma Ingredient Revenue, 2017-2028
6.4.2 By Country - North America Active Pharma Ingredient Sales, 2017-2028
6.4.3 US Active Pharma Ingredient Market Size, 2017-2028
6.4.4 Canada Active Pharma Ingredient Market Size, 2017-2028
6.4.5 Mexico Active Pharma Ingredient Market Size, 2017-2028
6.5 Europe
6.5.1 By Country - Europe Active Pharma Ingredient Revenue, 2017-2028
6.5.2 By Country - Europe Active Pharma Ingredient Sales, 2017-2028
6.5.3 Germany Active Pharma Ingredient Market Size, 2017-2028
6.5.4 France Active Pharma Ingredient Market Size, 2017-2028
6.5.5 U.K. Active Pharma Ingredient Market Size, 2017-2028
6.5.6 Italy Active Pharma Ingredient Market Size, 2017-2028
6.5.7 Russia Active Pharma Ingredient Market Size, 2017-2028
6.5.8 Nordic Countries Active Pharma Ingredient Market Size, 2017-2028
6.5.9 Benelux Active Pharma Ingredient Market Size, 2017-2028
6.6 Asia
6.6.1 By Region - Asia Active Pharma Ingredient Revenue, 2017-2028
6.6.2 By Region - Asia Active Pharma Ingredient Sales, 2017-2028
6.6.3 China Active Pharma Ingredient Market Size, 2017-2028
6.6.4 Japan Active Pharma Ingredient Market Size, 2017-2028
6.6.5 South Korea Active Pharma Ingredient Market Size, 2017-2028
6.6.6 Southeast Asia Active Pharma Ingredient Market Size, 2017-2028
6.6.7 India Active Pharma Ingredient Market Size, 2017-2028
6.7 South America
6.7.1 By Country - South America Active Pharma Ingredient Revenue, 2017-2028
6.7.2 By Country - South America Active Pharma Ingredient Sales, 2017-2028
6.7.3 Brazil Active Pharma Ingredient Market Size, 2017-2028
6.7.4 Argentina Active Pharma Ingredient Market Size, 2017-2028
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Active Pharma Ingredient Revenue, 2017-2028
6.8.2 By Country - Middle East & Africa Active Pharma Ingredient Sales, 2017-2028
6.8.3 Turkey Active Pharma Ingredient Market Size, 2017-2028
6.8.4 Israel Active Pharma Ingredient Market Size, 2017-2028
6.8.5 Saudi Arabia Active Pharma Ingredient Market Size, 2017-2028
6.8.6 UAE Active Pharma Ingredient Market Size, 2017-2028
7 MANUFACTURERS & BRANDS PROFILES
7.1 Teva
7.1.1 Teva Corporate Summary
7.1.2 Teva Business Overview
7.1.3 Teva Active Pharma Ingredient Major Product Offerings
7.1.4 Teva Active Pharma Ingredient Sales and Revenue in Global (2017-2022)
7.1.5 Teva Key News
7.2 Novartis
7.2.1 Novartis Corporate Summary
7.2.2 Novartis Business Overview
7.2.3 Novartis Active Pharma Ingredient Major Product Offerings
7.2.4 Novartis Active Pharma Ingredient Sales and Revenue in Global (2017-2022)
7.2.5 Novartis Key News
7.3 Pfizer
7.3.1 Pfizer Corporate Summary
7.3.2 Pfizer Business Overview
7.3.3 Pfizer Active Pharma Ingredient Major Product Offerings
7.3.4 Pfizer Active Pharma Ingredient Sales and Revenue in Global (2017-2022)
7.3.5 Pfizer Key News
7.4 Johnson & Johnson
7.4.1 Johnson & Johnson Corporate Summary
7.4.2 Johnson & Johnson Business Overview
7.4.3 Johnson & Johnson Active Pharma Ingredient Major Product Offerings
7.4.4 Johnson & Johnson Active Pharma Ingredient Sales and Revenue in Global (2017-2022)
7.4.5 Johnson & Johnson Key News
7.5 Mylan
7.5.1 Mylan Corporate Summary
7.5.2 Mylan Business Overview
7.5.3 Mylan Active Pharma Ingredient Major Product Offerings
7.5.4 Mylan Active Pharma Ingredient Sales and Revenue in Global (2017-2022)
7.5.5 Mylan Key News
7.6 North China Pharmaceutical Group
7.6.1 North China Pharmaceutical Group Corporate Summary
7.6.2 North China Pharmaceutical Group Business Overview
7.6.3 North China Pharmaceutical Group Active Pharma Ingredient Major Product Offerings
7.6.4 North China Pharmaceutical Group Active Pharma Ingredient Sales and Revenue in Global (2017-2022)
7.6.5 North China Pharmaceutical Group Key News
7.7 Dr. Reddy’s Laboratories
7.7.1 Dr. Reddy’s Laboratories Corporate Summary
7.7.2 Dr. Reddy’s Laboratories Business Overview
7.7.3 Dr. Reddy’s Laboratories Active Pharma Ingredient Major Product Offerings
7.7.4 Dr. Reddy’s Laboratories Active Pharma Ingredient Sales and Revenue in Global (2017-2022)
7.7.5 Dr. Reddy’s Laboratories Key News
7.8 Roche
7.8.1 Roche Corporate Summary
7.8.2 Roche Business Overview
7.8.3 Roche Active Pharma Ingredient Major Product Offerings
7.8.4 Roche Active Pharma Ingredient Sales and Revenue in Global (2017-2022)
7.8.5 Roche Key News
7.9 Aurobindo pharma
7.9.1 Aurobindo pharma Corporate Summary
7.9.2 Aurobindo pharma Business Overview
7.9.3 Aurobindo pharma Active Pharma Ingredient Major Product Offerings
7.9.4 Aurobindo pharma Active Pharma Ingredient Sales and Revenue in Global (2017-2022)
7.9.5 Aurobindo pharma Key News
7.10 Sun Pharmaceutical Industries
7.10.1 Sun Pharmaceutical Industries Corporate Summary
7.10.2 Sun Pharmaceutical Industries Business Overview
7.10.3 Sun Pharmaceutical Industries Active Pharma Ingredient Major Product Offerings
7.10.4 Sun Pharmaceutical Industries Active Pharma Ingredient Sales and Revenue in Global (2017-2022)
7.10.5 Sun Pharmaceutical Industries Key News
7.11 Boehringer Ingelheim GmbH
7.11.1 Boehringer Ingelheim GmbH Corporate Summary
7.11.2 Boehringer Ingelheim GmbH Active Pharma Ingredient Business Overview
7.11.3 Boehringer Ingelheim GmbH Active Pharma Ingredient Major Product Offerings
7.11.4 Boehringer Ingelheim GmbH Active Pharma Ingredient Sales and Revenue in Global (2017-2022)
7.11.5 Boehringer Ingelheim GmbH Key News
7.12 Bayer
7.12.1 Bayer Corporate Summary
7.12.2 Bayer Active Pharma Ingredient Business Overview
7.12.3 Bayer Active Pharma Ingredient Major Product Offerings
7.12.4 Bayer Active Pharma Ingredient Sales and Revenue in Global (2017-2022)
7.12.5 Bayer Key News
7.13 BASF
7.13.1 BASF Corporate Summary
7.13.2 BASF Active Pharma Ingredient Business Overview
7.13.3 BASF Active Pharma Ingredient Major Product Offerings
7.13.4 BASF Active Pharma Ingredient Sales and Revenue in Global (2017-2022)
7.13.5 BASF Key News
7.14 DSM
7.14.1 DSM Corporate Summary
7.14.2 DSM Business Overview
7.14.3 DSM Active Pharma Ingredient Major Product Offerings
7.14.4 DSM Active Pharma Ingredient Sales and Revenue in Global (2017-2022)
7.14.5 DSM Key News
7.15 Zhejiang Medicine
7.15.1 Zhejiang Medicine Corporate Summary
7.15.2 Zhejiang Medicine Business Overview
7.15.3 Zhejiang Medicine Active Pharma Ingredient Major Product Offerings
7.15.4 Zhejiang Medicine Active Pharma Ingredient Sales and Revenue in Global (2017-2022)
7.15.5 Zhejiang Medicine Key News
7.16 Biocon
7.16.1 Biocon Corporate Summary
7.16.2 Biocon Business Overview
7.16.3 Biocon Active Pharma Ingredient Major Product Offerings
7.16.4 Biocon Active Pharma Ingredient Sales and Revenue in Global (2017-2022)
7.16.5 Biocon Key News
7.17 Johnson Matthey
7.17.1 Johnson Matthey Corporate Summary
7.17.2 Johnson Matthey Business Overview
7.17.3 Johnson Matthey Active Pharma Ingredient Major Product Offerings
7.17.4 Johnson Matthey Active Pharma Ingredient Sales and Revenue in Global (2017-2022)
7.17.5 Johnson Matthey Key News
7.18 Hisun Pharmacy
7.18.1 Hisun Pharmacy Corporate Summary
7.18.2 Hisun Pharmacy Business Overview
7.18.3 Hisun Pharmacy Active Pharma Ingredient Major Product Offerings
7.18.4 Hisun Pharmacy Active Pharma Ingredient Sales and Revenue in Global (2017-2022)
7.18.5 Hisun Pharmacy Key News
7.19 Cambrex
7.19.1 Cambrex Corporate Summary
7.19.2 Cambrex Business Overview
7.19.3 Cambrex Active Pharma Ingredient Major Product Offerings
7.19.4 Cambrex Active Pharma Ingredient Sales and Revenue in Global (2017-2022)
7.19.5 Cambrex Key News
7.20 Shandong Xinhua Pharmaceutical
7.20.1 Shandong Xinhua Pharmaceutical Corporate Summary
7.20.2 Shandong Xinhua Pharmaceutical Business Overview
7.20.3 Shandong Xinhua Pharmaceutical Active Pharma Ingredient Major Product Offerings
7.20.4 Shandong Xinhua Pharmaceutical Active Pharma Ingredient Sales and Revenue in Global (2017-2022)
7.20.5 Shandong Xinhua Pharmaceutical Key News
7.21 Lonza group
7.21.1 Lonza group Corporate Summary
7.21.2 Lonza group Business Overview
7.21.3 Lonza group Active Pharma Ingredient Major Product Offerings
7.21.4 Lonza group Active Pharma Ingredient Sales and Revenue in Global (2017-2022)
7.21.5 Lonza group Key News
7.22 Huahai Pharmaceutical
7.22.1 Huahai Pharmaceutical Corporate Summary
7.22.2 Huahai Pharmaceutical Business Overview
7.22.3 Huahai Pharmaceutical Active Pharma Ingredient Major Product Offerings
7.22.4 Huahai Pharmaceutical Active Pharma Ingredient Sales and Revenue in Global (2017-2022)
7.22.5 Huahai Pharmaceutical Key News
7.23 Haerbin Pharmaceutical Group
7.23.1 Haerbin Pharmaceutical Group Corporate Summary
7.23.2 Haerbin Pharmaceutical Group Business Overview
7.23.3 Haerbin Pharmaceutical Group Active Pharma Ingredient Major Product Offerings
7.23.4 Haerbin Pharmaceutical Group Active Pharma Ingredient Sales and Revenue in Global (2017-2022)
7.23.5 Haerbin Pharmaceutical Group Key News
7.24 Cipla
7.24.1 Cipla Corporate Summary
7.24.2 Cipla Business Overview
7.24.3 Cipla Active Pharma Ingredient Major Product Offerings
7.24.4 Cipla Active Pharma Ingredient Sales and Revenue in Global (2017-2022)
7.24.5 Cipla Key News
7.25 Tian Yao
7.25.1 Tian Yao Corporate Summary
7.25.2 Tian Yao Business Overview
7.25.3 Tian Yao Active Pharma Ingredient Major Product Offerings
7.25.4 Tian Yao Active Pharma Ingredient Sales and Revenue in Global (2017-2022)
7.25.5 Tian Yao Key News
7.26 Lupin
7.26.1 Lupin Corporate Summary
7.26.2 Lupin Business Overview
7.26.3 Lupin Active Pharma Ingredient Major Product Offerings
7.26.4 Lupin Active Pharma Ingredient Sales and Revenue in Global (2017-2022)
7.26.5 Lupin Key News
7.27 North East Pharmaceutical
7.27.1 North East Pharmaceutical Corporate Summary
7.27.2 North East Pharmaceutical Business Overview
7.27.3 North East Pharmaceutical Active Pharma Ingredient Major Product Offerings
7.27.4 North East Pharmaceutical Active Pharma Ingredient Sales and Revenue in Global (2017-2022)
7.27.5 North East Pharmaceutical Key News
7.28 Albemarle
7.28.1 Albemarle Corporate Summary
7.28.2 Albemarle Business Overview
7.28.3 Albemarle Active Pharma Ingredient Major Product Offerings
7.28.4 Albemarle Active Pharma Ingredient Sales and Revenue in Global (2017-2022)
7.28.5 Albemarle Key News
7.29 Shandong Lukang Pharmaceutical
7.29.1 Shandong Lukang Pharmaceutical Corporate Summary
7.29.2 Shandong Lukang Pharmaceutical Business Overview
7.29.3 Shandong Lukang Pharmaceutical Active Pharma Ingredient Major Product Offerings
7.29.4 Shandong Lukang Pharmaceutical Active Pharma Ingredient Sales and Revenue in Global (2017-2022)
7.29.5 Shandong Lukang Pharmaceutical Key News
7.30 Jiangsu Hengrui Medicine
7.30.1 Jiangsu Hengrui Medicine Corporate Summary
7.30.2 Jiangsu Hengrui Medicine Business Overview
7.30.3 Jiangsu Hengrui Medicine Active Pharma Ingredient Major Product Offerings
7.30.4 Jiangsu Hengrui Medicine Active Pharma Ingredient Sales and Revenue in Global (2017-2022)
7.30.5 Jiangsu Hengrui Medicine Key News
8 GLOBAL ACTIVE PHARMA INGREDIENT PRODUCTION CAPACITY, ANALYSIS
8.1 Global Active Pharma Ingredient Production Capacity, 2017-2028
8.2 Active Pharma Ingredient Production Capacity of Key Manufacturers in Global Market
8.3 Global Active Pharma Ingredient Production by Region
9 KEY MARKET TRENDS, OPPORTUNITY, DRIVERS AND RESTRAINTS
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 ACTIVE PHARMA INGREDIENT SUPPLY CHAIN ANALYSIS
10.1 Active Pharma Ingredient Industry Value Chain
10.2 Active Pharma Ingredient Upstream Market
10.3 Active Pharma Ingredient Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Active Pharma Ingredient Distributors and Sales Agents in Global
11 CONCLUSION
12 APPENDIX
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES
Table 1. Key Players of Active Pharma Ingredient in Global Market
Table 2. Top Active Pharma Ingredient Players in Global Market, Ranking by Revenue (2021)
Table 3. Global Active Pharma Ingredient Revenue by Companies, (US$, Mn), 2017-2022
Table 4. Global Active Pharma Ingredient Revenue Share by Companies, 2017-2022
Table 5. Global Active Pharma Ingredient Sales by Companies, (K Pcs), 2017-2022
Table 6. Global Active Pharma Ingredient Sales Share by Companies, 2017-2022
Table 7. Key Manufacturers Active Pharma Ingredient Price (2017-2022) & (USD/Pcs)
Table 8. Global Manufacturers Active Pharma Ingredient Product Type
Table 9. List of Global Tier 1 Active Pharma Ingredient Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Active Pharma Ingredient Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Active Pharma Ingredient Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Global Active Pharma Ingredient Revenue (US$, Mn), 2017-2022
Table 13. By Type - Global Active Pharma Ingredient Revenue (US$, Mn), 2023-2028
Table 14. By Type - Global Active Pharma Ingredient Sales (K Pcs), 2017-2022
Table 15. By Type - Global Active Pharma Ingredient Sales (K Pcs), 2023-2028
Table 16. By Application – Global Active Pharma Ingredient Revenue, (US$, Mn), 2021 & 2028
Table 17. By Application - Global Active Pharma Ingredient Revenue (US$, Mn), 2017-2022
Table 18. By Application - Global Active Pharma Ingredient Revenue (US$, Mn), 2023-2028
Table 19. By Application - Global Active Pharma Ingredient Sales (K Pcs), 2017-2022
Table 20. By Application - Global Active Pharma Ingredient Sales (K Pcs), 2023-2028
Table 21. By Region – Global Active Pharma Ingredient Revenue, (US$, Mn), 2021 VS 2028
Table 22. By Region - Global Active Pharma Ingredient Revenue (US$, Mn), 2017-2022
Table 23. By Region - Global Active Pharma Ingredient Revenue (US$, Mn), 2023-2028
Table 24. By Region - Global Active Pharma Ingredient Sales (K Pcs), 2017-2022
Table 25. By Region - Global Active Pharma Ingredient Sales (K Pcs), 2023-2028
Table 26. By Country - North America Active Pharma Ingredient Revenue, (US$, Mn), 2017-2022
Table 27. By Country - North America Active Pharma Ingredient Revenue, (US$, Mn), 2023-2028
Table 28. By Country - North America Active Pharma Ingredient Sales, (K Pcs), 2017-2022
Table 29. By Country - North America Active Pharma Ingredient Sales, (K Pcs), 2023-2028
Table 30. By Country - Europe Active Pharma Ingredient Revenue, (US$, Mn), 2017-2022
Table 31. By Country - Europe Active Pharma Ingredient Revenue, (US$, Mn), 2023-2028
Table 32. By Country - Europe Active Pharma Ingredient Sales, (K Pcs), 2017-2022
Table 33. By Country - Europe Active Pharma Ingredient Sales, (K Pcs), 2023-2028
Table 34. By Region - Asia Active Pharma Ingredient Revenue, (US$, Mn), 2017-2022
Table 35. By Region - Asia Active Pharma Ingredient Revenue, (US$, Mn), 2023-2028
Table 36. By Region - Asia Active Pharma Ingredient Sales, (K Pcs), 2017-2022
Table 37. By Region - Asia Active Pharma Ingredient Sales, (K Pcs), 2023-2028
Table 38. By Country - South America Active Pharma Ingredient Revenue, (US$, Mn), 2017-2022
Table 39. By Country - South America Active Pharma Ingredient Revenue, (US$, Mn), 2023-2028
Table 40. By Country - South America Active Pharma Ingredient Sales, (K Pcs), 2017-2022
Table 41. By Country - South America Active Pharma Ingredient Sales, (K Pcs), 2023-2028
Table 42. By Country - Middle East & Africa Active Pharma Ingredient Revenue, (US$, Mn), 2017-2022
Table 43. By Country - Middle East & Africa Active Pharma Ingredient Revenue, (US$, Mn), 2023-2028
Table 44. By Country - Middle East & Africa Active Pharma Ingredient Sales, (K Pcs), 2017-2022
Table 45. By Country - Middle East & Africa Active Pharma Ingredient Sales, (K Pcs), 2023-2028
Table 46. Teva Corporate Summary
Table 47. Teva Active Pharma Ingredient Product Offerings
Table 48. Teva Active Pharma Ingredient Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 49. Novartis Corporate Summary
Table 50. Novartis Active Pharma Ingredient Product Offerings
Table 51. Novartis Active Pharma Ingredient Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 52. Pfizer Corporate Summary
Table 53. Pfizer Active Pharma Ingredient Product Offerings
Table 54. Pfizer Active Pharma Ingredient Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 55. Johnson & Johnson Corporate Summary
Table 56. Johnson & Johnson Active Pharma Ingredient Product Offerings
Table 57. Johnson & Johnson Active Pharma Ingredient Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 58. Mylan Corporate Summary
Table 59. Mylan Active Pharma Ingredient Product Offerings
Table 60. Mylan Active Pharma Ingredient Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 61. North China Pharmaceutical Group Corporate Summary
Table 62. North China Pharmaceutical Group Active Pharma Ingredient Product Offerings
Table 63. North China Pharmaceutical Group Active Pharma Ingredient Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 64. Dr. Reddy’s Laboratories Corporate Summary
Table 65. Dr. Reddy’s Laboratories Active Pharma Ingredient Product Offerings
Table 66. Dr. Reddy’s Laboratories Active Pharma Ingredient Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 67. Roche Corporate Summary
Table 68. Roche Active Pharma Ingredient Product Offerings
Table 69. Roche Active Pharma Ingredient Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 70. Aurobindo pharma Corporate Summary
Table 71. Aurobindo pharma Active Pharma Ingredient Product Offerings
Table 72. Aurobindo pharma Active Pharma Ingredient Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 73. Sun Pharmaceutical Industries Corporate Summary
Table 74. Sun Pharmaceutical Industries Active Pharma Ingredient Product Offerings
Table 75. Sun Pharmaceutical Industries Active Pharma Ingredient Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 76. Boehringer Ingelheim GmbH Corporate Summary
Table 77. Boehringer Ingelheim GmbH Active Pharma Ingredient Product Offerings
Table 78. Boehringer Ingelheim GmbH Active Pharma Ingredient Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 79. Bayer Corporate Summary
Table 80. Bayer Active Pharma Ingredient Product Offerings
Table 81. Bayer Active Pharma Ingredient Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 82. BASF Corporate Summary
Table 83. BASF Active Pharma Ingredient Product Offerings
Table 84. BASF Active Pharma Ingredient Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 85. DSM Corporate Summary
Table 86. DSM Active Pharma Ingredient Product Offerings
Table 87. DSM Active Pharma Ingredient Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 88. Zhejiang Medicine Corporate Summary
Table 89. Zhejiang Medicine Active Pharma Ingredient Product Offerings
Table 90. Zhejiang Medicine Active Pharma Ingredient Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 91. Biocon Corporate Summary
Table 92. Biocon Active Pharma Ingredient Product Offerings
Table 93. Biocon Active Pharma Ingredient Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 94. Johnson Matthey Corporate Summary
Table 95. Johnson Matthey Active Pharma Ingredient Product Offerings
Table 96. Johnson Matthey Active Pharma Ingredient Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 97. Hisun Pharmacy Corporate Summary
Table 98. Hisun Pharmacy Active Pharma Ingredient Product Offerings
Table 99. Hisun Pharmacy Active Pharma Ingredient Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 100. Cambrex Corporate Summary
Table 101. Cambrex Active Pharma Ingredient Product Offerings
Table 102. Cambrex Active Pharma Ingredient Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 103. Shandong Xinhua Pharmaceutical Corporate Summary
Table 104. Shandong Xinhua Pharmaceutical Active Pharma Ingredient Product Offerings
Table 105. Shandong Xinhua Pharmaceutical Active Pharma Ingredient Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 106. Lonza group Corporate Summary
Table 107. Lonza group Active Pharma Ingredient Product Offerings
Table 108. Lonza group Active Pharma Ingredient Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 109. Huahai Pharmaceutical Corporate Summary
Table 110. Huahai Pharmaceutical Active Pharma Ingredient Product Offerings
Table 111. Huahai Pharmaceutical Active Pharma Ingredient Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 112. Haerbin Pharmaceutical Group Corporate Summary
Table 113. Haerbin Pharmaceutical Group Active Pharma Ingredient Product Offerings
Table 114. Haerbin Pharmaceutical Group Active Pharma Ingredient Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 115. Cipla Corporate Summary
Table 116. Cipla Active Pharma Ingredient Product Offerings
Table 117. Cipla Active Pharma Ingredient Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 118. Tian Yao Corporate Summary
Table 119. Tian Yao Active Pharma Ingredient Product Offerings
Table 120. Tian Yao Active Pharma Ingredient Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 121. Lupin Corporate Summary
Table 122. Lupin Active Pharma Ingredient Product Offerings
Table 123. Lupin Active Pharma Ingredient Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 124. North East Pharmaceutical Corporate Summary
Table 125. North East Pharmaceutical Active Pharma Ingredient Product Offerings
Table 126. North East Pharmaceutical Active Pharma Ingredient Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 127. Albemarle Corporate Summary
Table 128. Albemarle Active Pharma Ingredient Product Offerings
Table 129. Albemarle Active Pharma Ingredient Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 130. Shandong Lukang Pharmaceutical Corporate Summary
Table 131. Shandong Lukang Pharmaceutical Active Pharma Ingredient Product Offerings
Table 132. Shandong Lukang Pharmaceutical Active Pharma Ingredient Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 133. Jiangsu Hengrui Medicine Corporate Summary
Table 134. Jiangsu Hengrui Medicine Active Pharma Ingredient Product Offerings
Table 135. Jiangsu Hengrui Medicine Active Pharma Ingredient Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 136. Active Pharma Ingredient Production Capacity (K Pcs) of Key Manufacturers in Global Market, 2020-2022 (K Pcs)
Table 137. Global Active Pharma Ingredient Capacity Market Share of Key Manufacturers, 2020-2022
Table 138. Global Active Pharma Ingredient Production by Region, 2017-2022 (K Pcs)
Table 139. Global Active Pharma Ingredient Production by Region, 2023-2028 (K Pcs)
Table 140. Active Pharma Ingredient Market Opportunities & Trends in Global Market
Table 141. Active Pharma Ingredient Market Drivers in Global Market
Table 142. Active Pharma Ingredient Market Restraints in Global Market
Table 143. Active Pharma Ingredient Raw Materials
Table 144. Active Pharma Ingredient Raw Materials Suppliers in Global Market
Table 145. Typical Active Pharma Ingredient Downstream
Table 146. Active Pharma Ingredient Downstream Clients in Global Market
Table 147. Active Pharma Ingredient Distributors and Sales Agents in Global Market
Table 1. Key Players of Active Pharma Ingredient in Global Market
Table 2. Top Active Pharma Ingredient Players in Global Market, Ranking by Revenue (2021)
Table 3. Global Active Pharma Ingredient Revenue by Companies, (US$, Mn), 2017-2022
Table 4. Global Active Pharma Ingredient Revenue Share by Companies, 2017-2022
Table 5. Global Active Pharma Ingredient Sales by Companies, (K Pcs), 2017-2022
Table 6. Global Active Pharma Ingredient Sales Share by Companies, 2017-2022
Table 7. Key Manufacturers Active Pharma Ingredient Price (2017-2022) & (USD/Pcs)
Table 8. Global Manufacturers Active Pharma Ingredient Product Type
Table 9. List of Global Tier 1 Active Pharma Ingredient Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Active Pharma Ingredient Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Active Pharma Ingredient Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Global Active Pharma Ingredient Revenue (US$, Mn), 2017-2022
Table 13. By Type - Global Active Pharma Ingredient Revenue (US$, Mn), 2023-2028
Table 14. By Type - Global Active Pharma Ingredient Sales (K Pcs), 2017-2022
Table 15. By Type - Global Active Pharma Ingredient Sales (K Pcs), 2023-2028
Table 16. By Application – Global Active Pharma Ingredient Revenue, (US$, Mn), 2021 & 2028
Table 17. By Application - Global Active Pharma Ingredient Revenue (US$, Mn), 2017-2022
Table 18. By Application - Global Active Pharma Ingredient Revenue (US$, Mn), 2023-2028
Table 19. By Application - Global Active Pharma Ingredient Sales (K Pcs), 2017-2022
Table 20. By Application - Global Active Pharma Ingredient Sales (K Pcs), 2023-2028
Table 21. By Region – Global Active Pharma Ingredient Revenue, (US$, Mn), 2021 VS 2028
Table 22. By Region - Global Active Pharma Ingredient Revenue (US$, Mn), 2017-2022
Table 23. By Region - Global Active Pharma Ingredient Revenue (US$, Mn), 2023-2028
Table 24. By Region - Global Active Pharma Ingredient Sales (K Pcs), 2017-2022
Table 25. By Region - Global Active Pharma Ingredient Sales (K Pcs), 2023-2028
Table 26. By Country - North America Active Pharma Ingredient Revenue, (US$, Mn), 2017-2022
Table 27. By Country - North America Active Pharma Ingredient Revenue, (US$, Mn), 2023-2028
Table 28. By Country - North America Active Pharma Ingredient Sales, (K Pcs), 2017-2022
Table 29. By Country - North America Active Pharma Ingredient Sales, (K Pcs), 2023-2028
Table 30. By Country - Europe Active Pharma Ingredient Revenue, (US$, Mn), 2017-2022
Table 31. By Country - Europe Active Pharma Ingredient Revenue, (US$, Mn), 2023-2028
Table 32. By Country - Europe Active Pharma Ingredient Sales, (K Pcs), 2017-2022
Table 33. By Country - Europe Active Pharma Ingredient Sales, (K Pcs), 2023-2028
Table 34. By Region - Asia Active Pharma Ingredient Revenue, (US$, Mn), 2017-2022
Table 35. By Region - Asia Active Pharma Ingredient Revenue, (US$, Mn), 2023-2028
Table 36. By Region - Asia Active Pharma Ingredient Sales, (K Pcs), 2017-2022
Table 37. By Region - Asia Active Pharma Ingredient Sales, (K Pcs), 2023-2028
Table 38. By Country - South America Active Pharma Ingredient Revenue, (US$, Mn), 2017-2022
Table 39. By Country - South America Active Pharma Ingredient Revenue, (US$, Mn), 2023-2028
Table 40. By Country - South America Active Pharma Ingredient Sales, (K Pcs), 2017-2022
Table 41. By Country - South America Active Pharma Ingredient Sales, (K Pcs), 2023-2028
Table 42. By Country - Middle East & Africa Active Pharma Ingredient Revenue, (US$, Mn), 2017-2022
Table 43. By Country - Middle East & Africa Active Pharma Ingredient Revenue, (US$, Mn), 2023-2028
Table 44. By Country - Middle East & Africa Active Pharma Ingredient Sales, (K Pcs), 2017-2022
Table 45. By Country - Middle East & Africa Active Pharma Ingredient Sales, (K Pcs), 2023-2028
Table 46. Teva Corporate Summary
Table 47. Teva Active Pharma Ingredient Product Offerings
Table 48. Teva Active Pharma Ingredient Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 49. Novartis Corporate Summary
Table 50. Novartis Active Pharma Ingredient Product Offerings
Table 51. Novartis Active Pharma Ingredient Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 52. Pfizer Corporate Summary
Table 53. Pfizer Active Pharma Ingredient Product Offerings
Table 54. Pfizer Active Pharma Ingredient Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 55. Johnson & Johnson Corporate Summary
Table 56. Johnson & Johnson Active Pharma Ingredient Product Offerings
Table 57. Johnson & Johnson Active Pharma Ingredient Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 58. Mylan Corporate Summary
Table 59. Mylan Active Pharma Ingredient Product Offerings
Table 60. Mylan Active Pharma Ingredient Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 61. North China Pharmaceutical Group Corporate Summary
Table 62. North China Pharmaceutical Group Active Pharma Ingredient Product Offerings
Table 63. North China Pharmaceutical Group Active Pharma Ingredient Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 64. Dr. Reddy’s Laboratories Corporate Summary
Table 65. Dr. Reddy’s Laboratories Active Pharma Ingredient Product Offerings
Table 66. Dr. Reddy’s Laboratories Active Pharma Ingredient Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 67. Roche Corporate Summary
Table 68. Roche Active Pharma Ingredient Product Offerings
Table 69. Roche Active Pharma Ingredient Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 70. Aurobindo pharma Corporate Summary
Table 71. Aurobindo pharma Active Pharma Ingredient Product Offerings
Table 72. Aurobindo pharma Active Pharma Ingredient Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 73. Sun Pharmaceutical Industries Corporate Summary
Table 74. Sun Pharmaceutical Industries Active Pharma Ingredient Product Offerings
Table 75. Sun Pharmaceutical Industries Active Pharma Ingredient Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 76. Boehringer Ingelheim GmbH Corporate Summary
Table 77. Boehringer Ingelheim GmbH Active Pharma Ingredient Product Offerings
Table 78. Boehringer Ingelheim GmbH Active Pharma Ingredient Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 79. Bayer Corporate Summary
Table 80. Bayer Active Pharma Ingredient Product Offerings
Table 81. Bayer Active Pharma Ingredient Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 82. BASF Corporate Summary
Table 83. BASF Active Pharma Ingredient Product Offerings
Table 84. BASF Active Pharma Ingredient Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 85. DSM Corporate Summary
Table 86. DSM Active Pharma Ingredient Product Offerings
Table 87. DSM Active Pharma Ingredient Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 88. Zhejiang Medicine Corporate Summary
Table 89. Zhejiang Medicine Active Pharma Ingredient Product Offerings
Table 90. Zhejiang Medicine Active Pharma Ingredient Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 91. Biocon Corporate Summary
Table 92. Biocon Active Pharma Ingredient Product Offerings
Table 93. Biocon Active Pharma Ingredient Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 94. Johnson Matthey Corporate Summary
Table 95. Johnson Matthey Active Pharma Ingredient Product Offerings
Table 96. Johnson Matthey Active Pharma Ingredient Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 97. Hisun Pharmacy Corporate Summary
Table 98. Hisun Pharmacy Active Pharma Ingredient Product Offerings
Table 99. Hisun Pharmacy Active Pharma Ingredient Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 100. Cambrex Corporate Summary
Table 101. Cambrex Active Pharma Ingredient Product Offerings
Table 102. Cambrex Active Pharma Ingredient Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 103. Shandong Xinhua Pharmaceutical Corporate Summary
Table 104. Shandong Xinhua Pharmaceutical Active Pharma Ingredient Product Offerings
Table 105. Shandong Xinhua Pharmaceutical Active Pharma Ingredient Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 106. Lonza group Corporate Summary
Table 107. Lonza group Active Pharma Ingredient Product Offerings
Table 108. Lonza group Active Pharma Ingredient Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 109. Huahai Pharmaceutical Corporate Summary
Table 110. Huahai Pharmaceutical Active Pharma Ingredient Product Offerings
Table 111. Huahai Pharmaceutical Active Pharma Ingredient Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 112. Haerbin Pharmaceutical Group Corporate Summary
Table 113. Haerbin Pharmaceutical Group Active Pharma Ingredient Product Offerings
Table 114. Haerbin Pharmaceutical Group Active Pharma Ingredient Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 115. Cipla Corporate Summary
Table 116. Cipla Active Pharma Ingredient Product Offerings
Table 117. Cipla Active Pharma Ingredient Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 118. Tian Yao Corporate Summary
Table 119. Tian Yao Active Pharma Ingredient Product Offerings
Table 120. Tian Yao Active Pharma Ingredient Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 121. Lupin Corporate Summary
Table 122. Lupin Active Pharma Ingredient Product Offerings
Table 123. Lupin Active Pharma Ingredient Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 124. North East Pharmaceutical Corporate Summary
Table 125. North East Pharmaceutical Active Pharma Ingredient Product Offerings
Table 126. North East Pharmaceutical Active Pharma Ingredient Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 127. Albemarle Corporate Summary
Table 128. Albemarle Active Pharma Ingredient Product Offerings
Table 129. Albemarle Active Pharma Ingredient Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 130. Shandong Lukang Pharmaceutical Corporate Summary
Table 131. Shandong Lukang Pharmaceutical Active Pharma Ingredient Product Offerings
Table 132. Shandong Lukang Pharmaceutical Active Pharma Ingredient Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 133. Jiangsu Hengrui Medicine Corporate Summary
Table 134. Jiangsu Hengrui Medicine Active Pharma Ingredient Product Offerings
Table 135. Jiangsu Hengrui Medicine Active Pharma Ingredient Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 136. Active Pharma Ingredient Production Capacity (K Pcs) of Key Manufacturers in Global Market, 2020-2022 (K Pcs)
Table 137. Global Active Pharma Ingredient Capacity Market Share of Key Manufacturers, 2020-2022
Table 138. Global Active Pharma Ingredient Production by Region, 2017-2022 (K Pcs)
Table 139. Global Active Pharma Ingredient Production by Region, 2023-2028 (K Pcs)
Table 140. Active Pharma Ingredient Market Opportunities & Trends in Global Market
Table 141. Active Pharma Ingredient Market Drivers in Global Market
Table 142. Active Pharma Ingredient Market Restraints in Global Market
Table 143. Active Pharma Ingredient Raw Materials
Table 144. Active Pharma Ingredient Raw Materials Suppliers in Global Market
Table 145. Typical Active Pharma Ingredient Downstream
Table 146. Active Pharma Ingredient Downstream Clients in Global Market
Table 147. Active Pharma Ingredient Distributors and Sales Agents in Global Market
LIST OF FIGURES
Figure 1. Active Pharma Ingredient Segment by Type
Figure 2. Active Pharma Ingredient Segment by Application
Figure 3. Global Active Pharma Ingredient Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Active Pharma Ingredient Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Active Pharma Ingredient Revenue, 2017-2028 (US$, Mn)
Figure 7. Active Pharma Ingredient Sales in Global Market: 2017-2028 (K Pcs)
Figure 8. The Top 3 and 5 Players Market Share by Active Pharma Ingredient Revenue in 2021
Figure 9. By Type - Global Active Pharma Ingredient Sales Market Share, 2017-2028
Figure 10. By Type - Global Active Pharma Ingredient Revenue Market Share, 2017-2028
Figure 11. By Type - Global Active Pharma Ingredient Price (USD/Pcs), 2017-2028
Figure 12. By Application - Global Active Pharma Ingredient Sales Market Share, 2017-2028
Figure 13. By Application - Global Active Pharma Ingredient Revenue Market Share, 2017-2028
Figure 14. By Application - Global Active Pharma Ingredient Price (USD/Pcs), 2017-2028
Figure 15. By Region - Global Active Pharma Ingredient Sales Market Share, 2017-2028
Figure 16. By Region - Global Active Pharma Ingredient Revenue Market Share, 2017-2028
Figure 17. By Country - North America Active Pharma Ingredient Revenue Market Share, 2017-2028
Figure 18. By Country - North America Active Pharma Ingredient Sales Market Share, 2017-2028
Figure 19. US Active Pharma Ingredient Revenue, (US$, Mn), 2017-2028
Figure 20. Canada Active Pharma Ingredient Revenue, (US$, Mn), 2017-2028
Figure 21. Mexico Active Pharma Ingredient Revenue, (US$, Mn), 2017-2028
Figure 22. By Country - Europe Active Pharma Ingredient Revenue Market Share, 2017-2028
Figure 23. By Country - Europe Active Pharma Ingredient Sales Market Share, 2017-2028
Figure 24. Germany Active Pharma Ingredient Revenue, (US$, Mn), 2017-2028
Figure 25. France Active Pharma Ingredient Revenue, (US$, Mn), 2017-2028
Figure 26. U.K. Active Pharma Ingredient Revenue, (US$, Mn), 2017-2028
Figure 27. Italy Active Pharma Ingredient Revenue, (US$, Mn), 2017-2028
Figure 28. Russia Active Pharma Ingredient Revenue, (US$, Mn), 2017-2028
Figure 29. Nordic Countries Active Pharma Ingredient Revenue, (US$, Mn), 2017-2028
Figure 30. Benelux Active Pharma Ingredient Revenue, (US$, Mn), 2017-2028
Figure 31. By Region - Asia Active Pharma Ingredient Revenue Market Share, 2017-2028
Figure 32. By Region - Asia Active Pharma Ingredient Sales Market Share, 2017-2028
Figure 33. China Active Pharma Ingredient Revenue, (US$, Mn), 2017-2028
Figure 34. Japan Active Pharma Ingredient Revenue, (US$, Mn), 2017-2028
Figure 35. South Korea Active Pharma Ingredient Revenue, (US$, Mn), 2017-2028
Figure 36. Southeast Asia Active Pharma Ingredient Revenue, (US$, Mn), 2017-2028
Figure 37. India Active Pharma Ingredient Revenue, (US$, Mn), 2017-2028
Figure 38. By Country - South America Active Pharma Ingredient Revenue Market Share, 2017-2028
Figure 39. By Country - South America Active Pharma Ingredient Sales Market Share, 2017-2028
Figure 40. Brazil Active Pharma Ingredient Revenue, (US$, Mn), 2017-2028
Figure 41. Argentina Active Pharma Ingredient Revenue, (US$, Mn), 2017-2028
Figure 42. By Country - Middle East & Africa Active Pharma Ingredient Revenue Market Share, 2017-2028
Figure 43. By Country - Middle East & Africa Active Pharma Ingredient Sales Market Share, 2017-2028
Figure 44. Turkey Active Pharma Ingredient Revenue, (US$, Mn), 2017-2028
Figure 45. Israel Active Pharma Ingredient Revenue, (US$, Mn), 2017-2028
Figure 46. Saudi Arabia Active Pharma Ingredient Revenue, (US$, Mn), 2017-2028
Figure 47. UAE Active Pharma Ingredient Revenue, (US$, Mn), 2017-2028
Figure 48. Global Active Pharma Ingredient Production Capacity (K Pcs), 2017-2028
Figure 49. The Percentage of Production Active Pharma Ingredient by Region, 2021 VS 2028
Figure 50. Active Pharma Ingredient Industry Value Chain
Figure 51. Marketing Channels
Figure 1. Active Pharma Ingredient Segment by Type
Figure 2. Active Pharma Ingredient Segment by Application
Figure 3. Global Active Pharma Ingredient Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Active Pharma Ingredient Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Active Pharma Ingredient Revenue, 2017-2028 (US$, Mn)
Figure 7. Active Pharma Ingredient Sales in Global Market: 2017-2028 (K Pcs)
Figure 8. The Top 3 and 5 Players Market Share by Active Pharma Ingredient Revenue in 2021
Figure 9. By Type - Global Active Pharma Ingredient Sales Market Share, 2017-2028
Figure 10. By Type - Global Active Pharma Ingredient Revenue Market Share, 2017-2028
Figure 11. By Type - Global Active Pharma Ingredient Price (USD/Pcs), 2017-2028
Figure 12. By Application - Global Active Pharma Ingredient Sales Market Share, 2017-2028
Figure 13. By Application - Global Active Pharma Ingredient Revenue Market Share, 2017-2028
Figure 14. By Application - Global Active Pharma Ingredient Price (USD/Pcs), 2017-2028
Figure 15. By Region - Global Active Pharma Ingredient Sales Market Share, 2017-2028
Figure 16. By Region - Global Active Pharma Ingredient Revenue Market Share, 2017-2028
Figure 17. By Country - North America Active Pharma Ingredient Revenue Market Share, 2017-2028
Figure 18. By Country - North America Active Pharma Ingredient Sales Market Share, 2017-2028
Figure 19. US Active Pharma Ingredient Revenue, (US$, Mn), 2017-2028
Figure 20. Canada Active Pharma Ingredient Revenue, (US$, Mn), 2017-2028
Figure 21. Mexico Active Pharma Ingredient Revenue, (US$, Mn), 2017-2028
Figure 22. By Country - Europe Active Pharma Ingredient Revenue Market Share, 2017-2028
Figure 23. By Country - Europe Active Pharma Ingredient Sales Market Share, 2017-2028
Figure 24. Germany Active Pharma Ingredient Revenue, (US$, Mn), 2017-2028
Figure 25. France Active Pharma Ingredient Revenue, (US$, Mn), 2017-2028
Figure 26. U.K. Active Pharma Ingredient Revenue, (US$, Mn), 2017-2028
Figure 27. Italy Active Pharma Ingredient Revenue, (US$, Mn), 2017-2028
Figure 28. Russia Active Pharma Ingredient Revenue, (US$, Mn), 2017-2028
Figure 29. Nordic Countries Active Pharma Ingredient Revenue, (US$, Mn), 2017-2028
Figure 30. Benelux Active Pharma Ingredient Revenue, (US$, Mn), 2017-2028
Figure 31. By Region - Asia Active Pharma Ingredient Revenue Market Share, 2017-2028
Figure 32. By Region - Asia Active Pharma Ingredient Sales Market Share, 2017-2028
Figure 33. China Active Pharma Ingredient Revenue, (US$, Mn), 2017-2028
Figure 34. Japan Active Pharma Ingredient Revenue, (US$, Mn), 2017-2028
Figure 35. South Korea Active Pharma Ingredient Revenue, (US$, Mn), 2017-2028
Figure 36. Southeast Asia Active Pharma Ingredient Revenue, (US$, Mn), 2017-2028
Figure 37. India Active Pharma Ingredient Revenue, (US$, Mn), 2017-2028
Figure 38. By Country - South America Active Pharma Ingredient Revenue Market Share, 2017-2028
Figure 39. By Country - South America Active Pharma Ingredient Sales Market Share, 2017-2028
Figure 40. Brazil Active Pharma Ingredient Revenue, (US$, Mn), 2017-2028
Figure 41. Argentina Active Pharma Ingredient Revenue, (US$, Mn), 2017-2028
Figure 42. By Country - Middle East & Africa Active Pharma Ingredient Revenue Market Share, 2017-2028
Figure 43. By Country - Middle East & Africa Active Pharma Ingredient Sales Market Share, 2017-2028
Figure 44. Turkey Active Pharma Ingredient Revenue, (US$, Mn), 2017-2028
Figure 45. Israel Active Pharma Ingredient Revenue, (US$, Mn), 2017-2028
Figure 46. Saudi Arabia Active Pharma Ingredient Revenue, (US$, Mn), 2017-2028
Figure 47. UAE Active Pharma Ingredient Revenue, (US$, Mn), 2017-2028
Figure 48. Global Active Pharma Ingredient Production Capacity (K Pcs), 2017-2028
Figure 49. The Percentage of Production Active Pharma Ingredient by Region, 2021 VS 2028
Figure 50. Active Pharma Ingredient Industry Value Chain
Figure 51. Marketing Channels
